Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel grant Innovation Bridge 2025 India

Reference number
Coordinator Prolevi Bio AB
Funding from Vinnova SEK 25 000
Project duration November 2025 - November 2025
Status Ongoing
Venture Global cooperation 2025

Purpose and goal

1. Secure funding for capital raising 2. Meet with branded generic pharmaceutical companies from India 3. Negotiate licensing rights in Asia

Expected effects and result

Prospective shareholders are based in India as it is top market for branded generics. We would extend the trip further to meet potential shareholders from the delegation and their networks, which would help Prolevi secure international funding

Planned approach and implementation

Networking and fundraising at pitch event and mingling

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 13 October 2025

Reference number 2025-04212